Aldactone: Effective Potassium-Sparing Diuretic Therapy
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.11 | $66.34 (0%) | 🛒 Add to cart |
| 90 | $1.04 | $99.51 $93.48 (6%) | 🛒 Add to cart |
| 120 | $1.01 | $132.68 $121.62 (8%) | 🛒 Add to cart |
| 180 | $0.99 | $199.01 $177.91 (11%) | 🛒 Add to cart |
| 270 | $0.96 | $298.52 $260.33 (13%) | 🛒 Add to cart |
| 360 | $0.96
Best per pill | $398.03 $346.77 (13%) | 🛒 Add to cart |
Aldactone (spironolactone) is a prescription medication classified as a potassium-sparing diuretic, widely utilized in clinical practice for its targeted action on the renin-angiotensin-aldosterone system. It is primarily indicated for the management of conditions such as heart failure, hypertension, edema associated with hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism. Its mechanism involves competitive antagonism of aldosterone receptors, promoting sodium and water excretion while conserving potassium, thereby addressing fluid retention and electrolyte imbalances with a well-established efficacy and safety profile.
Features
- Active ingredient: Spironolactone
- Available in 25 mg, 50 mg, and 100 mg oral tablets
- Potassium-sparing diuretic class
- Competitively antagonizes aldosterone at mineralocorticoid receptors
- Bioavailability of approximately 90% when taken orally
- Metabolized extensively in the liver to active metabolites, including canrenone
- Half-life ranges from 1.3 to 2 hours for spironolactone and 16.5 hours for canrenone
- Excreted primarily via renal and biliary pathways
Benefits
- Effectively reduces edema and fluid overload in heart failure and hepatic cirrhosis
- Helps lower blood pressure in patients with essential or secondary hypertension
- Prevents hypokalemia by conserving potassium, reducing the need for supplementation
- Provides targeted treatment for primary hyperaldosteronism (Conn’s syndrome)
- May improve survival in selected heart failure patients when used as adjunct therapy
- Reduces proteinuria in certain kidney-related conditions
Common use
Aldactone is commonly prescribed for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and nephrotic syndrome. It is also indicated for essential hypertension, particularly in patients requiring potassium conservation or those with demonstrated aldosterone excess. Additionally, it is used diagnostically and therapeutically in primary hyperaldosteronism, and off-label for conditions such as hirsutism in polycystic ovary syndrome (PCOS) due to its anti-androgenic properties.
Dosage and direction
Dosage must be individualized based on the condition being treated and patient response. For edema in adults: initial dose is typically 100 mg daily in single or divided doses, adjust to 25–200 mg daily. For hypertension: initial dose 50–100 mg daily, adjust as needed. For primary hyperaldosteronism: doses may range from 100–400 mg daily. Administer with meals to enhance absorption. Regular monitoring of serum electrolytes and renal function is essential during therapy. Dosage adjustments are necessary in renal impairment.
Precautions
Use with caution in patients with renal impairment, electrolyte imbalances, or metabolic acidosis. Avoid in anuria, acute renal insufficiency, or significant impairment of renal function. Monitor potassium levels regularly, especially when used with other potassium-sparing agents, ACE inhibitors, ARBs, or potassium supplements. May cause hyperkalemia, particularly in diabetic patients and those with renal insufficiency. Use cautiously in hepatic impairment due to risk of electrolyte imbalance and dehydration. May cause gynecomastia, impotence, or menstrual irregularities.
Contraindications
Aldactone is contraindicated in patients with anuria, acute renal insufficiency, significant renal impairment (CrCl <30 mL/min), or hyperkalemia. Contraindicated in patients with Addison’s disease and hypersensitivity to spironolactone or any component of the formulation. Avoid use concomitantly with eplerenone due to additive effects.
Possible side effect
Common side effects include dizziness, headache, gastrointestinal disturbances (nausea, vomiting, diarrhea), gynecomastia, impotence, menstrual irregularities, and rash. Hyperkalemia is a serious potential adverse effect, particularly in at-risk patients. Less commonly, may cause hyponatremia, hyperchloremic metabolic acidosis, drowsiness, lethargy, ataxia, or photosensitivity. Rare reports of severe hypersensitivity reactions, including Stevens-Johnson syndrome.
Drug interaction
Significant interactions include increased risk of hyperkalemia with ACE inhibitors, ARBs, potassium supplements, NSAIDs, heparin, and other potassium-sparing diuretics. May enhance the effects of other antihypertensive agents. NSAIDs may reduce diuretic and antihypertensive efficacy. Spironolactone may increase lithium levels and toxicity risk. May interfere with digoxin assays. Use cautiously with other nephrotoxic drugs.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose. Do not double the dose to make up for a missed one. Maintain regular dosing schedule to ensure consistent therapeutic effect.
Overdose
Symptoms of overdose may include drowsiness, confusion, rash, nausea, vomiting, dizziness, diarrhea, hyperkalemia, hyponatremia, or dehydration. Management involves supportive care, including gastric lavage if recent ingestion, correction of electrolyte imbalances, and symptomatic treatment. Hemodialysis may not be effective due to high protein binding.
Storage
Store at controlled room temperature (20–25°C or 68–77°F), in a tightly closed container, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and individualized treatment recommendations. Do not initiate or discontinue medication without medical supervision.
Reviews
Aldactone is generally well-regarded in clinical practice for its efficacy in managing fluid overload and hypertension while conserving potassium. Many clinicians appreciate its role in heart failure regimens and its utility in specific endocrine disorders. Some patients report satisfaction with its effects, though side effects like gynecomastia or menstrual changes may limit long-term use in certain individuals. Overall, it remains a valuable therapeutic option within its indicated uses.